22Jan
Blog: Cooley’s 2020 Life Sciences M&A Year in Review
General Trends in Life Sciences M&A - If 2019 was the year of life sciences mega-deals, 2020 was the year of COVID-19, as the global pandemic permeated every aspect of the dealmaking landscape, with the life sciences sector being no exception. COVID-19 drove unprecedented levels of collaboration among biopharmaceutical companies seeking to develop a vaccine, leading to an accelerated research and development process that allowed not just one—but two—vaccines to be approved by the FDA in...
By:
Cooley LLP
Related
As we began to describe on March 18, the economic impacts of the ongoing coronavirus/COVID-19 pandem...
Read More >
The new state law reflects a trend among other states including New Hampshire, Maine, Maryland, Oreg...
Read More >
So about those May jobs numbers . . . . The return of 2.5 million jobs in May was a welcome and larg...
Read More >
Many California local ordinances have mid-year minimum wage rate increases effective July 1, 2019. O...
Read More >
Despite news of additional COVID-19-related deaths and infections in America, central bankers appear...
Read More >
Chicago Mayor Lori Lightfoot is expected to sign into law the City Council’s recently passed Chicag...
Read More >